View Rule

View EO 12866 Meetings Printer-Friendly Version     Download RIN Data in XML

DOJ/DEA RIN: 1117-AB71 Publication ID: Fall 2023 
Title: Medical Missions 

DEA proposes to create a new regulation to govern medical missions as well as amend existing to allow practitioners engaged in medical missions to export controlled substances as a coincident activity to the dispensing business activity. DEA has historically granted Medical Mission Waiver Letters, authorizing practitioners to export Schedule II-V controlled substances to a foreign country in furtherance of a medical mission. Because the Controlled Substances Import-Export Act (the non-domestic portion of the CSA) contains specific statutory export requirements that cannot be waived, and because DEA is prohibited from issuing improper guidance, it is necessary to regulate and clarify the application and recordkeeping requirements for medical missions.

Agency: Department of Justice(DOJ)  Priority: Substantive, Nonsignificant 
RIN Status: Previously published in the Unified Agenda Agenda Stage of Rulemaking: Proposed Rule Stage 
Major: No  Unfunded Mandates: No 
CFR Citation: 21 CFR 1301   
Legal Authority: 21 U.S.C. 821, 827, 871(b)   
Legal Deadline:  None
Action Date FR Cite
NPRM  11/00/2023 
Additional Information: DEA docket number 754
Regulatory Flexibility Analysis Required: No  Government Levels Affected: None 
Small Entities Affected: Organizations  Federalism: No 
Included in the Regulatory Plan: No 
RIN Information URL:   Public Comment URL:  
RIN Data Printed in the FR: No 
Agency Contact:
Scott A. Brinks
Section Chief, Regulatory Drafting and Support Section, Diversion Control Division
Department of Justice
Drug Enforcement Administration
8701 Morrissette Drive,
Springfield, VA 22152
Phone:571 362-8209